NEUROLOGY 1992;42:1468
© 1992 American Academy of Neurology
A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis
B. G. Weinshenker, MD,
M. Penman, RN,
B. Bass, RN,
G. C. Ebers, MD and
G. P. A. Rice, MD
From Ottawa General Hospital (Dr. Weinshenker), Ottawa, and University Hospital (M. Penman, B. Bass, and Drs. Ebers and Rice), London, ON, Canada.
Fatigue occurs in a majority of patients with MS and is generally independent of measurable neurologic disability. Few options for treatment are available. We conducted a double-blind, placebo-controlled, crossover trial for each of two 4-week treatment periods. Forty-six eligible patients entered and five dropped out due to concurrent exacerbations. Nineteen patients (46.3%) experienced excellent or good relief of fatigue with pemoline, and eight patients (19.5%) with placebo (p = 0.06, Fisher's exact test). One-fourth of patients did not tolerate the drug well, and 7% had to discontinue pemoline during the study due to side effects. The most common side effects were anorexia, irritability, and insomnia. Pemoline may be an effective short-term treatment for fatigue associated with MS, but its adverse effects are not well tolerated by many patients.
Address correspondence and reprint requests to Dr. B.G. Weinshenker, Division of Neurology, Mayo Clinic, Rochester, MN 55905.
Received October 15, 1991. Accepted for publication in final form January 28, 1992.
This article has been cited by other articles:
|
|
|
|
 
A Spathis, R Dhillan, D Booden, K Forbes, K Vrotsou, and K Fife
Modafinil for the treatment of fatigue in lung cancer: a pilot study
Palliative Medicine,
June 1, 2009;
23(4):
325 - 331.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Kos, E. Kerckhofs, G. Nagels, M.B. D'hooghe, and S. Ilsbroukx
Origin of Fatigue in Multiple Sclerosis: Review of the Literature
Neurorehabil Neural Repair,
February 1, 2008;
22(1):
91 - 100.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. van Kessel, R. Moss-Morris, E. Willoughby, T. Chalder, M. H. Johnson, and E. Robinson
A Randomized Controlled Trial of Cognitive Behavior Therapy for Multiple Sclerosis Fatigue
Psychosom Med,
February 1, 2008;
70(2):
205 - 213.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. K. Carroll, S. Kohli, K. M. Mustian, J. A. Roscoe, and G. R. Morrow
Pharmacologic Treatment of Cancer-Related Fatigue
Oncologist,
May 1, 2007;
12(suppl_1):
43 - 51.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.G. Beiske, H. Naess, J.H. Aarseth, O. Andersen, I. Elovaara, M. Farkkila, H.J. Hansen, S.I. Mellgren, M. Sandberg-Wollheim, P.S. Sorensen, et al.
Health-related quality of life in secondary progressive multiple sclerosis
Multiple Sclerosis,
April 1, 2007;
13(3):
386 - 392.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. R. Schwid and T. J. Murray
Treating fatigue in patients with MS: One step forward, one step back
Neurology,
April 12, 2005;
64(7):
1111 - 1112.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Stankoff, E. Waubant, C. Confavreux, G. Edan, M. Debouverie, L. Rumbach, T. Moreau, J. Pelletier, C. Lubetzki, M. Clanet, et al.
Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study
Neurology,
April 12, 2005;
64(7):
1139 - 1143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Crayton, R. A. Heyman, and H. S. Rossman
A multimodal approach to managing the symptoms of multiple sclerosis
Neurology,
December 14, 2004;
63(11_suppl_5):
S12 - S18.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
V. Mock
Evidence-Based Treatment for Cancer-Related Fatigue
J Natl Cancer Inst Monographs,
July 1, 2004;
2004(32):
112 - 118.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. C. Mohr, S. L. Hart, and A. Goldberg
Effects of Treatment for Depression on Fatigue in Multiple Sclerosis
Psychosom Med,
July 1, 2003;
65(4):
542 - 547.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Bakshi
Fatigue associated with multiple sclerosis: diagnosis, impact and management
Multiple Sclerosis,
June 1, 2003;
9(3):
219 - 227.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. T. Schapiro
Pharmacologic Options for the Management of Multiple Sclerosis Symptoms
Neurorehabil Neural Repair,
September 1, 2002;
16(3):
223 - 231.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. B. Krupp and S. A. Rizvi
Symptomatic therapy for underrecognized manifestations of multiple sclerosis
Neurology,
April 23, 2002;
58(90084):
S32 - 39.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K W Rammohan, J H Rosenberg, D J Lynn, A M Blumenfeld, C P Pollak, and H N Nagaraja
Efficacy and safety of modafinil (Provigil(R)) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study
J. Neurol. Neurosurg. Psychiatry,
February 1, 2002;
72(2):
179 - 183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Breitbart, B. Rosenfeld, M. Kaim, and J. Funesti-Esch
A Randomized, Double-blind, Placebo-Controlled Trial of Psychostimulants for the Treatment of Fatigue in Ambulatory Patients With Human Immunodeficiency Virus Disease
Arch Intern Med,
February 12, 2001;
161(3):
411 - 420.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R Bakshi, Z A Shaikh, R S Miletich, D Czarnecki, J Dmochowski, K Henschel, V Janardhan, N Dubey, and P R Kinkel
Fatigue in multiple sclerosis and its relationship to depression and neurologic disability
Multiple Sclerosis,
June 1, 2000;
6(3):
181 - 185.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. C Kroencke, S. G Lynch, and D. R Denney
Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern
Multiple Sclerosis,
April 1, 2000;
6(2):
131 - 136.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J Iriarte, G Katsamakis, and P De Castro
The fatigue descriptive scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis
Multiple Sclerosis,
February 1, 1999;
5(1):
010 - 16.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. R. Rosh, S. F. Dellert, M. Narkewicz, A. Birnbaum, and G. Whitington
Four Cases of Severe Hepatotoxicity Associated With Pemoline: Possible Autoimmune Pathogenesis
Pediatrics,
May 1, 1998;
101(5):
921 - 923.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Geisler, M. Sliwinski, P. K. Coyle, D. M. Masur, C. Doscher, and L. B. Krupp
The Effects of Amantadine and Pemoline on Cognitive Functioning in Multiple Sclerosis
Arch Neurol,
February 1, 1996;
53(2):
185 - 188.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Copperman, C. Hartley, P. Scharf, and R. W. Hicks
Fatigue and Mobility
Neurorehabil Neural Repair,
January 1, 1994;
8(3):
131 - 136.
[Abstract]
[PDF]
|
|
|
|
